Trial site
Zhongda Hospital
- 13running trials
- 5closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer11 trials
- Prostate cancer5 trials
- Ovarian cancer2 trials
- Childhood cancers1 trial
- Hepatitis B1 trial
- Phase
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting9 trials
- Completed5 trials
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Zhongda Hospital11 trials
- baotai Liang4 trials
- Beijing Gene Key Life Technology Co., Ltd1 trial
- Peking University First Hospital1 trial
- Suzhou Mednovo Yi Medical Technology Co., Ltd.1 trial
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
Recruiting
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer7 recruiting
- Prostate cancer5 recruiting
- Hepatitis B1 recruiting
Closed trials
Completed
Completed
Completed
Recruiting
Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026